查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2058615

基於 CRISPR 的基因組編輯市場：按產品/服務、應用、最終用途、國家和地區分類－全球產業分析、市場規模、市場佔有率及 2026 年至 2033 年預測

CRISPR-based Gene Editing Market, By Product & Service, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年，以CRISPR為基礎的基因組編輯市值為46.052億美元，預計從2026年到2033年將以15.1%的複合年成長率成長。

基於 CRISPR 的基因組編輯是指一系列用於精確修改生物體內 DNA 序列的先進生物技術。這使得研究人員能夠在特定位置添加、移除或改變遺傳物質，從而提高基因工程的準確性和效率。基於 CRISPR 的基因組編輯市場代表著分子生物學和生物技術領域的一項重大進步，它能夠實現極其精確且高效的基因組修飾。例如，美國國立衛生研究院 (NIH) 網站 2025 年發布的一項關於分子生物學進展的調查顯示，現代分子生物學已擴展到單細胞層面的生物系統分析，從而能夠在每次實驗中檢測數千至數百萬個單一細胞的基因表現變化。這與傳統的群體層級方法形成鮮明對比，後者是對整個組織訊號進行平均。這種精確度有望加速創新，並擴大 CRISPR 在治療領域的應用。

基於CRISPR的基因組編輯市場－市場動態

遺傳性疾病盛行率的上升正在推動市場需求。

隨著基因測序和臨床基因組學的進步，遺傳性疾病的日益活性化，推動了對罕見和先前未確診的神經發育障礙的研究。近期的一些發現，例如新發現的RPS6KC1等基因突變，加深了我們對複雜神經系統和發育障礙的理解。這些進展增強了早期診斷能力，並加速了針對罕見遺傳性疾病的標靶治療的研發。

全球遺傳疾病盛行率的不斷上升推動了對基於 CRISPR 的基因組編輯技術的需求。這是因為該技術能夠精確地修改致病突變，從而支持標靶性新一代基因治療方法的開發。例如，美國疾病管制與預防中心 (CDC) 2026 年發布的《基因組學與健康概覽》報告指出，遺傳疾病是由多種 DNA 變化引起的，從單基因突變到染色體異常，甚至包括多個基因與環境因素之間的複雜相互作用。根據 CDC 的報告，罕見疾病和遺傳疾病包括單基因疾病和染色體異常，例如唐氏症（約每 700 名新生兒中就有 1 例），以及囊腫纖維化等疾病（在美國約有 35,000 人患有此病）。因此，CRISPR 技術在精準、個人化且可能治癒遺傳疾病的治療方法的應用正在加速發展。

基於 CRISPR 的基因組編輯市場—市場區隔分析：

全球基於 CRISPR 的基因組編輯市場按產品和服務、應用、最終用途和地區進行細分。

從產品和服務角度來看，CRISPR試劑盒和試劑在基於CRISPR的基因組編輯市場中佔據了相當大的佔有率，這得益於它們在基因組編輯工作流程中的廣泛應用、在研究中的高採用率以及在基因改造中的關鍵作用。例如，印度政府藥品管理局的一項研究強調，對試劑盒和試劑需求的成長顯著推動了印度醫療設備產業的擴張。報告指出，診斷檢測需求的成長使印度對體外診斷試劑的進口依賴度增加了約65.4%，達到約8.72億美元。此外，受醫療篩檢和檢測基礎設施擴張的推動，醫療設備進口額達到約85億美元，成長了36.8%。因此，診斷和研究應用的擴展正在加速全球對CRISPR試劑盒和試劑的需求。

從應用領域來看，生物醫學領域在基於CRISPR的基因組編輯市場中佔據主導地位。這主要得益於CRISPR技術在治療方法研發、遺傳疾病治療、腫瘤研究、疾病診斷等領域的廣泛應用，以及體外和體內基因編輯技術的日益普及。例如，經合組織2025年的一項調查顯示，日本對生物醫學和先進醫療保健技術的使用正在成長。日本的醫療保健支出約佔其GDP的10.6%，人均醫療支出接近5,790美元，且100%的人口享有醫療保險。此外，日本每百萬人擁有約184台CT、MRI和PET掃描儀，每十萬人擁有約203名藥劑師，顯示先進醫療保健技術的應用十分廣泛。醫療保健基礎設施的不斷改進正在加速生物醫學技術在基於CRISPR的基因組編輯市場中的應用。

基於 CRISPR 的基因組編輯市場—區域洞察

北美在基於 CRISPR 的基因組編輯市場佔據重要地位，這得益於眾多大型生物技術和製藥公司的存在以及對研發的持續投入。 2025 年 4 月，丹納赫公司透過旗下 Integrated DNA Technologies (IDT) 和 Aldevron 兩家公司加強了其研發生態系統，從而提升了其基於 CRISPR 的基因組編輯能力。該公司致力於生產高品質的 DNA、RNA 和 CRISPR 工具，旨在加速下一代基因編輯療法的開發，並提高個人化治療方案的擴充性。這將進一步鞏固北美在 CRISPR 創新和治療方法開發領域的領先地位。

此外，在生物技術和製藥行業的蓬勃發展推動下，基於CRISPR的基因組編輯市場預計將在亞太地區快速成長。中國、日本、韓國和印度等國在政府支持和政策改革的推動下，正大力投資基因組研究、臨床試驗和基於CRISPR的產品開發。根據印度新聞資訊局（PIB）2025年5月在新德里國家農業科學中心（NASC）的巴拉特·拉特納·C·蘇布拉馬尼亞姆禮堂宣布，印度聯邦農業和農民福利部長希夫拉傑·辛格·喬漢宣布了印度首批基因組編輯水稻品種“DRR Rice 100 (Kamra)”和“Pusa DST Rice 1”。這些品種由印度農業研究理事會（ICAR）利用基於CRISPR的基因組編輯技術開發，具有增產、增強氣候適應性和節水等優點。憑藉著這項成果，印度成為全球第一個成功研發出基因組編輯稻米品種的國家。因此，亞太地區憑藉著強大的創新能力和政策支持，引領了 CRISPR 技術的應用。

中國在基於CRISPR的基因編輯市場中扮演著舉足輕重的角色，是第一個利用CRISPR-Cas9技術進行針對遺傳疾病的人體臨床試驗的國家。例如，美國國立衛生研究院（NIH）強調，中國現代臨床試驗體系的快速發展，使其從早期參與人數極少的對照人體試驗，發展成為如今大規模、多中心、隨機對照的臨床研究生態系統。在進入系統性臨床研究階段時，中國已在腫瘤、循環系統疾病、感染疾病和傳統醫學等關鍵治療領域進行了數百項多中心隨機對照試驗。現代臨床試驗的II期/III期試驗參與者人數從數百人到超過3000人不等，與幾十年前不足100人相比，這是一個顯著的成長。因此，中國臨床研究的擴展正在加速CRISPR基因編輯技術的進步。

目錄

第1章：基於CRISPR的基因組編輯市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：基於CRISPR的基因組編輯的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：基於CRISPR的基因組編輯產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：基於CRISPR的基因組編輯市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：基於CRISPR的基因組編輯市場趨勢

  • 基於 CRISPR 的基因組編輯市佔分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：基於 CRISPR 的基因組編輯市場：按產品和服務分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品/服務
    • 產品
      • CRISPR 文庫
      • CRISPR試劑盒和試劑
      • 其他
    • 服務
    • 其他

第8章：基於 CRISPR 的基因組編輯市場：按應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 按配送方式
      • Ex Vivo
      • 體內
    • 疾病診斷
    • 在農業領域的應用
      • 牲畜基因工程
      • 工廠工程
      • 其他
    • 生物醫學
      • 藥物研發
      • 適應症
      • 眼科
      • 腫瘤學
      • 遺傳性疾病
      • 其他

第9章：基於CRISPR的基因組編輯市場：依最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 受託研究機構
    • 學術研究機構
    • 製藥和生物技術公司
    • 其他

第10章：基於 CRISPR 的基因組編輯市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：基於 CRISPR 的基因組編輯產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript Biotech Corporation
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Tocris Bioscience
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories
    • Bio-Techne Corporation
    • New England Biolabs, Inc.
    • CRISPR Therapeutics AG
    • Agilent Technologies, Inc.
    • GeneCopoeia, Inc.
    • Synthego Corporation
    • System Biosciences LLC
    • ToolGen, Inc.
    • Rockland Immunochemicals, Inc.
    • Horizon Discovery Group
    • Abcam, Inc.
    • Applied StemCell, Inc.
    • Cellecta, Inc.
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6595

CRISPR-based Gene Editing Market size was valued at US$ 4,605.2 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.

CRISPR-based gene editing refers to a set of advanced biotechnology tools used to precisely modify DNA sequences within living organisms. It enables researchers to add, remove, or alter genetic material at specific locations, improving accuracy and efficiency in genetic engineering. The CRISPR-based Gene Editing market represents a major advancement in molecular biology and biotechnology, enabling highly precise and efficient genome modification. For instance, in 2025, research on advancements in molecular biology by NIH.gov highlights that modern molecular biology has expanded to analyze biological systems at single-cell resolution, enabling detection of gene expression variability across thousands to millions of individual cells per experiment, compared to earlier bulk-level methods that averaged signals across entire tissues. This precision is expected to accelerate innovation and expand CRISPR adoption in therapeutics.

CRISPR-based Gene Editing Market- Market Dynamics

Rising prevalence of genetic disorders to propel market demand

The rise of genetic disorders is driving increased research into rare and previously undiagnosed neurodevelopmental conditions, supported by advances in genome sequencing and clinical genomics. Recent discoveries, including newly identified mutations in genes such as RPS6KC1, are expanding understanding of complex neurological and developmental diseases. These advancements are strengthening early diagnosis capabilities and accelerating the development of targeted therapies for rare genetic disorders.

The rising prevalence of genetic disorders globally is driving demand for CRISP based gene editing, as it enables precise correction of disease-causing mutations and supports the development of targeted, next-generation genetic therapies. For instance, in 2026, insights from the CDC Gov., genomics, and health overview highlight that genetic disorders arise from changes in DNA ranging from single-gene mutations to chromosomal abnormalities and complex interactions between multiple genes and environmental factors. The CDC reports that rare and genetic conditions include single-gene and chromosomal disorders such as Down syndrome (~1 in 700 births) and diseases like cystic fibrosis affecting ~35,000 people in the U.S. Thus, accelerating CRISPR adoption for precise, personalized, and potentially curative genetic disease therapies.

CRISPR-based Gene Editing Market- Segmentation Analysis:

The Global CRISPR-based Gene Editing Market is segmented on the basis of Product & Service , Application, End Use, and Region.

From a product & service perspective, CRISPR kits & reagents hold a significant share in the CRISPR-based Gene Editing market due to their widespread use in genome editing workflows, high research adoption, and essential role in gene modification. For instance, research by the Department of Pharmaceuticals, Government of India, highlights that the growing demand for kits and reagents is significantly contributing to the expansion of India's medical devices industry. The report states that India's import dependence on IVD reagents increased by nearly 65.4%, reaching around USD 872 million due to rising diagnostic testing demand. Additionally, medical device imports touched approximately USD 8,500 million, growing by 36.8% with expanding healthcare screening and testing infrastructure. Thus, expanding diagnostic and research applications are accelerating global demand for CRISPR kits and reagents.

In terms of application, the biomedical segment represents a key area in the CRISPR-based Gene Editing market, driven by its expanding use in therapeutic development, genetic disorder treatment, oncology research, disease diagnostics, and the growing adoption of ex vivo and in vivo gene editing technologies. For instance, in 2025, research by the OECD org. highlights that Japan is witnessing growing use of biomedical and advanced healthcare technologies. Japan spends around 10.6% of GDP on healthcare, with per capita healthcare expenditure reaching nearly USD 5,790 and universal coverage for 100% of the population. The country also has approximately 184 CT, MRI, and PET scanners per million people and around 203 pharmacists per 100,000 population, reflecting strong adoption of advanced healthcare technologies. The expanding healthcare infrastructure is accelerating biomedical adoption in the CRISPR-based Gene Editing market.

CRISPR-based Gene Editing Market- Geographical Insights

North America holds a key position in the CRISPR-based Gene Editing market, driven by the presence of key biotechnology and pharmaceutical companies and continuous investments in research and development. In April 2025, Danaher Corporation advanced its CRISPR-based gene editing capabilities by strengthening its research and development ecosystem through Integrated DNA Technologies (IDT) and Aldevron, focusing on high-quality DNA, RNA, and CRISPR tool production to accelerate development of next-generation gene editing therapies and improve scalability of personalized treatment solutions. And this strengthens North America's leadership in CRISPR innovation and therapeutic development.

Moreover, Asia-Pacific is expected to grow at a rapid pace in the CRISPR-based Gene Editing market, supported by the expansion of biotechnology and pharmaceutical industries. Countries such as China, Japan, South Korea, and India are making significant investments in genomic research, clinical trials, and CRISPR-based product development, driven by supportive government initiatives and progressive policy reforms. In May 2025, as stated by PIB Gov., at the Bharat Ratna C. Subramaniam Auditorium, NASC Complex, New Delhi, Union Agriculture and Farmers Welfare Minister Shri Shivraj Singh Chouhan launched India's first genome-edited rice varieties, DRR Rice 100 (Kamla) and Pusa DST Rice 1. Developed by ICAR using CRISPR-based genome editing, these varieties offer higher yield, improved climate adaptability, and better water conservation. With this launch, India became the first country to develop genome-edited rice varieties. Therefore, Asia-Pacific is leading CRISPR adoption through strong innovation and policy support.

China plays a key role in the CRISPR-based Gene Editing market, being the first country to conduct human clinical trials using CRISPR-Cas9 for genetic disorders. For instance, the NIH Gov. highlights that China's modern clinical trial system has rapidly expanded from minimal participation in early controlled human studies to a large-scale multicenter randomized clinical research ecosystem. By the structured clinical research phase, China had established hundreds of multicenter RCTs across major therapeutic areas, including oncology, cardiovascular, infectious diseases, and traditional medicine. Modern trials now involve several hundred to over 3,000 participants per Phase II/III study, up from fewer than 100 participants in earlier decades. Thus, China's clinical expansion is accelerating CRISPR gene editing advancements.

CRISPR-based Gene Editing Market- Competitive Landscape:

The CRISPR-based Gene Editing market is highly competitive and moderately consolidated, with several global and specialized biotechnology players driving innovation and commercialization. Leading companies such as CRISPR Therapeutics AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GeneCopoeia, Inc., and Synthego Corporation are strengthening their positions through advanced genome editing platforms, expanding research applications, and continuous product development in gene modification technologies. In May 2025, Danaher used its Business System to deliver the world's first mRNA-based personalized CRISPR therapy in under six months, accelerating treatment for a child with neonatal-onset CPS1 deficiency. Hence, ongoing innovation is accelerating CRISPR therapy development and clinical adoption globally.

Recent Developments:

In May 2025, Bio-Techne Corporation entered into a collaboration with Kytopen to integrate Flowfect(R) continuous flow technology with advanced gene delivery systems, enabling scalable non-viral CRISPR-mediated T-cell engineering and improving efficiency in cell therapy manufacturing workflows.

In April 2025, Synthego Corporation expanded its CRISPR licensing ecosystem through a strategic agreement with Vita Therapeutics to integrate high-fidelity hfCas12Max nuclease technology into next-generation cell therapy programs, enhancing precision and reducing off-target gene editing risks.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Revvity, Inc.
  • Danaher Corporation
  • GenScript Biotech Corporation
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Tocris Bioscience
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • New England Biolabs, Inc.
  • CRISPR Therapeutics AG
  • Agilent Technologies, Inc.
  • GeneCopoeia, Inc.
  • Synthego Corporation
  • System Biosciences LLC
  • ToolGen, Inc.
  • Rockland Immunochemicals, Inc.
  • Horizon Discovery Group
  • Abcam, Inc.
  • Applied StemCell, Inc.
  • Cellecta, Inc.
  • Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2020 - 2033

  • Products
  • CRISPR Libraries
  • CRISPR Kits & Reagents
  • Others
  • Services
  • Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • By Delivery Method
  • Ex Vivo
  • In Vivo
  • Disease Diagnostics
  • Agricultural applications
  • Farm Animals Engineering
  • Plant Engineering
  • Others
  • Biomedical
  • Therapeutic Development
  • By Indication
  • Ophthalmology
  • Oncology
  • Genetic Disorders
  • Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Contract Research Organizations
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. CRISPR-based Gene Editing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR-based Gene Editing Market Snippet by Product & Service
    • 2.1.2. CRISPR-based Gene Editing Market Snippet by Application
    • 2.1.3. CRISPR-based Gene Editing Market Snippet by End Use
    • 2.1.4. CRISPR-based Gene Editing Market Snippet by Country
    • 2.1.5. CRISPR-based Gene Editing Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR-based Gene Editing Key Market Trends

  • 3.1. CRISPR-based Gene Editing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR-based Gene Editing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR-based Gene Editing Market Opportunities
  • 3.4. CRISPR-based Gene Editing Market Future Trends

4. CRISPR-based Gene Editing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR-based Gene Editing Market : Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR-based Gene Editing Market Landscape

  • 6.1. CRISPR-based Gene Editing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR-based Gene Editing Market - By Product & Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product & Service , 2025 & 2033 (%)
    • 7.1.2. Products
      • 7.1.2.1. CRISPR Libraries
      • 7.1.2.2. CRISPR Kits & Reagents
      • 7.1.2.3. Others
    • 7.1.3. Services
    • 7.1.4. Others

8. CRISPR-based Gene Editing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. By Delivery Method
      • 8.1.2.1. Ex Vivo
      • 8.1.2.2. In Vivo
    • 8.1.3. Disease Diagnostics
    • 8.1.4. Agricultural applications
      • 8.1.4.1. Farm Animals Engineering
      • 8.1.4.2. Plant Engineering
      • 8.1.4.3. Others
    • 8.1.5. Biomedical
      • 8.1.5.1. Therapeutic Development
      • 8.1.5.1.1. By Indication
      • 8.1.5.1.2. Ophthalmology
      • 8.1.5.1.3. Oncology
      • 8.1.5.1.4. Genetic Disorders
      • 8.1.5.1.5. Others

9. CRISPR-based Gene Editing Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
    • 9.1.2. Contract Research Organizations
    • 9.1.3. Academic & Research Institutes
    • 9.1.4. Pharmaceutical & Biotechnology Companies
    • 9.1.5. Others

10. CRISPR-based Gene Editing Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CRISPR-based Gene Editing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CRISPR-based Gene Editing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CRISPR-based Gene Editing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. CRISPR-based Gene Editing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. CRISPR-based Gene Editing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- CRISPR-based Gene Editing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Revvity, Inc.
    • 11.2.2. Danaher Corporation
    • 11.2.3. GenScript Biotech Corporation
    • 11.2.4. Merck KGaA
    • 11.2.5. Thermo Fisher Scientific, Inc.
    • 11.2.6. Tocris Bioscience
    • 11.2.7. OriGene Technologies, Inc.
    • 11.2.8. Bio-Rad Laboratories
    • 11.2.9. Bio-Techne Corporation
    • 11.2.10. New England Biolabs, Inc.
    • 11.2.11. CRISPR Therapeutics AG
    • 11.2.12. Agilent Technologies, Inc.
    • 11.2.13. GeneCopoeia, Inc.
    • 11.2.14. Synthego Corporation
    • 11.2.15. System Biosciences LLC
    • 11.2.16. ToolGen, Inc.
    • 11.2.17. Rockland Immunochemicals, Inc.
    • 11.2.18. Horizon Discovery Group
    • 11.2.19. Abcam, Inc.
    • 11.2.20. Applied StemCell, Inc.
    • 11.2.21. Cellecta, Inc.
    • 11.2.22. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us